Abstract
Continuous administration of haloperidol, sulpiride, or cis-flupenthixol, but not of domperidone or apomorphine, to Wistar rats for up to 3 weeks caused an increase in spontaneous purposeless chewing movements. Treatment with physostigmine and pilocarpine, but not neostigmine, for up to 3 weeks increased chewing, whilst scopolamine decreased chewing. Metergoline and cyproheptadine, but not quipazine, increased chewing after only 1 and 7 days but not thereafter.
Chewing was not altered following treatment with compounds acting on GABA or noradrenaline systems or by a range of non-neuroleptic agents inducing dystonia in man.
The enhancement of chewing induced by neuroleptic and cholinomimetic drugs was reduced by acute treatment with scopolamine, and reverted to control levels following drug withdrawal.
Neuroleptic-induced purposeless chewing in Wistar rats appears to be primarily influenced by cerebral dopamine and acetylcholine function and may resemble acute dystonia, rather than tardive dyskinesia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Akindele O, Odejide AO (1976) Amodiaquine-induced involuntary movements. Br Med J 6029:213–215
Arneric SP, Collins ED, Bhatnagar RK, Lond JP (1982) Is domperidone a selective peripheral dopamine receptor antagonist in vivo? Neuropharmacology 21:1317–1321
Ayd FJ (1961) A survey of drug-induced extrapyramidal reactions. J Am Med Assoc 175:1054–1060
Bhargava RK, Parakh LK, Hakim A, Gori MN, Bhandari NC (1973) Extrapyramidal syndrome after antimalarials. J Assoc Physicions India 21:969–973
Bibbio G, Casu M, Corda MG, Vernaleone F, Gessa GL (1977) Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain. Life Sci 21:525–532
Carey RJ (1982) A comparison of atropine, benztropine and diphenhydramine on the reversal of haloperidol-induced suppression of self-stimulation. Pharmacol Biochem Behav 17:851–854
Carter CJ, Pycock CJ (1981) The role of 5-hydroxytryptamine in dopamine-dependent sterotyped behaviour. Neuropharmacology 20:261–265
Casey DE, Gerlach J, Christensson E (1980) Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacology 70:83–87
Chadwick D, Reynolds EH, Marsden CD (1976) Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatr 39:1210–1218
Clow A, Jenner P, Marsden CD (1979) Changes in dopamine-mediated behaviour during one year's neuroleptic administration. Eur J Pharmacol 57:365–375
Clow A, Theodorou A, Jenner P, Marsden CD (1980) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 63:145–157
Cochlin DL (1974) Dystonic reactions due to metoclopramide and phenothiazines resembling tetanus. Br J Clin Pract 28:201–202
Cools AR, Hendriks G, Korten J (1974) The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic dystonic, dyskinetic and epileptoid motor activities. J Neural Transm 36:81–105
Costain DW, Green AR (1978) β-adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine. Br J Pharmacol 64:193–200
Dill RE, Nickey WM, Little MD (1968) Dyskinesias in rats following chemical stimulation of the neostriatum. Texas Reports Biol Med 26:101–106
Elliot PNC, Jenner P, Chadwick D, Reynolds E, Marsden CD (1977) The effect of diphenylhydantoin on central catecholamine containing neuronal systems. J Pharm Pharmacol 29:41–43
Ernst AM (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacology 10:316–323
Garvey HL, Ram V (1975) Central induced hypotensive effects of β-adrenergic blocking drugs. Eur J Pharmacol 33:283–294
Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69:19–25
Gunne L-M, Barany S (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50:237–240
Gunne L-M, Barany S (1979) A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia. Psychopharmacology 63:195–198
Gunne L-M, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134–139
Iversen SD, Howells RB, Hughes RP (1980) Behavioural consequences of long-term treatment with neuroleptic drugs. Adv Biochem Psychopharmacol 24:305–313
Kobinger W, Pichler L (1975) The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Eur J Pharmacol 30:56–62
Krall RL, Penry JK, White BG, Kupferburg HJ, Swinyard EA (1978) Anti-epileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19:409–428
Liebman J, Neale R (1980) Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extra-pyramidal side effects. Psychopharmacology 68:25–29
Luscombe G, Jenner P, Marsden CD (1981) Pharmacological analysis of the myoclonus produced by 5-hydroxytryptamine in the guinea pig suggests the presence of multiple 5-hydroxytryptamine receptors in the brain. Neuropharmacology 20:819–831
Meldrum BS, Anlezark GM, Marsden CD (1977) Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain 100:313–326
Murphey DL, Dill RE (1972) Chemical stimulation of discrete brain loci as a method of producing dyskinesia models in primates. Exp Neurol 34:244–254
Neale R, Gerhardt S, Liebman JM (1984) Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacology 82:20–26
Osifo NG (1979) Drug-related transient dyskinesias. Clin Pharmacol Ther 25:767–771
Parkes JD, Bedard P, Marsden CD (1976) Chorea and torsion in Parkinsonism. Lancet 1:155
Paulson GW (1973) Dyskinesias in monkeys. In Barbeau A, Chase TN, Paulsin GW (eds) Huntington's Chorea. Raven Press, New York. Adv Neurol 1:647–650
Porsolt RD, Jalfre M (1981) Neuroleptic-induced acute dyskinesias in rhesus monkeys. Psychopharmacology 75:16–21
Pycock C, Dawbarn D, O'Shaughnessy C (1982) Behavioural and biochemical changes following chronic administration of l-dopa to rats. Eur J Pharmacol 79:201–215
Ramsden PD, Frogatt DL (1972) Idiosyncratic responses to phenothiazines. Br Med J 1:246
Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226–230
Schechter PJ, Tranier Y (1977) Effect of elevated brain GABA concentrations on the actions of bicuculline and picrotoxin in mice. Psychopharmacology 54:145–148
Singhi S, Singhi P, Singh M (1977) Chloroquine-induced involuntary movements. Br Med J 6085:520
Thach BT, Chase TN, Bosma JF (1975) Oral facial dyskinesia associated with prolonged use of antihistamine decongestants. New Eng J Med 293:486–487
Titeler M, Seeman P (1980) Radioreceptor labeling of pre- and postsynaptic dopamine receptors. In: Cattabeni F, Racagni G, Spano PF, Costa E (eds) Long-term effecs of neuroleptics. Raven Press, New York. Adv Biochem Psychopharmacol 24:159–165
Umez-Eronini E, Eronini EA (1977) Chloroquine-induced involuntary movements. Br Med J 6066:945–946
Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532
Yamada K, Furukawa T (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 67:39–43
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rupniak, N.M.J., Jenner, P. & Marsden, C.D. Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology 85, 71–79 (1985). https://doi.org/10.1007/BF00427326
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427326